Evidence map›Paper›PMID 42393507›Full record

ArticleBMC microbiology2026

Insights into antimicrobial resistance: dissemination and molecular epidemiology of carbapenemase and AmpC genes in uropathogenic Escherichia coli.

Maryam Shirzadian, Fatemeh Foroohi, Abbas Fallah Vosoughi, Shervindokht Ahmadi, Taha Golpasand, Payam Behzadi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maryam ShirzadianDepartment of Microbiology, ShQ.C., Islamic Azad University, Shahr-e Qods, Iran.
Fatemeh ForoohiDepartment of Microbiology, ShQ.C., Islamic Azad University, Shahr-e Qods, Iran.
Abbas Fallah VosoughiDepartment of Microbiology, ShQ.C., Islamic Azad University, Shahr-e Qods, Iran.
Shervindokht AhmadiDepartment of Microbiology, ShQ.C., Islamic Azad University, Shahr-e Qods, Iran.
Taha GolpasandDepartment of Microbiology, ShQ.C., Islamic Azad University, Shahr-e Qods, Iran.
Payam BehzadiDepartment of Microbiology, ShQ.C., Islamic Azad University, Shahr-e Qods, Iran. behzadipayam@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study investigated the prevalence of acquired/natural AmpC β-lactamase genes (ABLGs) and acquired carbapenemase genes (ACGs) and their association with antimicrobial resistance in uropathogenic Escherichia coli (UPEC).

methodsA total of 105 non-duplicate UPEC isolates recovered from urine specimens collected in Tehran, Iran (August 2023-January 2024), were analyzed. Antimicrobial susceptibility testing was performed by the Kirby-Bauer method. ESBL and AmpC phenotypes were determined phenotypically, and bla

resultsResistance to ampicillin and amoxicillin was observed in all isolates, followed by ciprofloxacin (75.24%), ofloxacin (60.95%), and cefotaxime (60.95%). ESBL and AmpC phenotypes were detected in 37.14% and 11.43% of isolates, respectively. MDR, XDR, and PDR phenotypes occurred in 55.24%, 16.19%, and 2.86% of isolates. The most prevalent β-lactamase genes (BLGs) were bla

conclusionsUPEC isolates from Tehran exhibited substantial antimicrobial resistance, including MDR, XDR, and PDR phenotypes. ESBL and AmpC producers were common, with bla

Indexed as

Bacterial Proteinsbeta-LactamasesEscherichia coli InfectionsUropathogenic Escherichia coliAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialHumansIranMicrobial Sensitivity TestsMolecular EpidemiologyUrinary Tract InfectionsAmpC beta-lactamasesAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseAmpC beta-lactamasesbeta-lactamasesCarbapenemaseUrinary tract infectionsUropathogenic Escherichia coli

Identifiers

PMID42393507
PMCPMC13595747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.